These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7446538)

  • 1. Use of simulation to develop multiple-dose regimens for drugs exhibiting nonlinear elimination kinetics.
    Hepler CD; Prince RA
    Am J Hosp Pharm; 1980 Dec; 37(12):1631-5. PubMed ID: 7446538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using pharmacokinetics in drug therapy. VI: Comparing methods for dealing with nonlinear drugs like phenytoin.
    Schumacher GE
    Am J Hosp Pharm; 1980 Jan; 37(1):128-32. PubMed ID: 7361770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using pharmacokinetics in drug therapy II: Rapid estimates of dosage regimens and blood levels without knowledge of pharmacokinetic variables.
    Schumacher GE; Griener JC
    Am J Hosp Pharm; 1978 Apr; 35(4):454-9. PubMed ID: 645719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic comparison of the one-point method with other methods in predicting steady state drug concentrations in multiple dosing.
    Ritschel WA; Erni W
    Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):279-87. PubMed ID: 881281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method for controlled establishment of steady-state plasma levels through multiple dosing.
    Weiss M; Förster W
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):102-4. PubMed ID: 649225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-calculated kanamycin dosage regimen and monitoring.
    Ritschel WA; Banarer M; Lau-Chang EF
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):121-5. PubMed ID: 844931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose size and dosing interval determination.
    Ritschel WA
    Arzneimittelforschung; 1975 Sep; 25(9):1442-7. PubMed ID: 1242670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Model building in pharmacokinetics/Part V: Simulation of blood level curves following repetitive dosing and their experimental verification (author's transl)].
    Hammer R; Bozler G; Heinzel G; Koss FW
    Arzneimittelforschung; 1977; 27(4a):928-31. PubMed ID: 577860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using pharmacokinetics in drug therapy III: Estimating dosage regimens and blood levels using the fraction-lost method.
    Schumacher GE
    Am J Hosp Pharm; 1978 Aug; 35(8):955-8. PubMed ID: 677145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualizing phenytoin dosage regimens using a programmable calculator.
    Ng PK
    Am J Hosp Pharm; 1980 Apr; 37(4):529-33. PubMed ID: 7377216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New generalized equations for multiple dose kinetics by i.v. injection.
    Hajratwala BR
    Pharmazie; 1976; 31(10):731-3. PubMed ID: 1019197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A calculator program to project serum drug concentration profiles during dosing schedules comprised of two fixed dosing intervals.
    Jones EM
    Int J Biomed Comput; 1982 Mar; 13(2):97-107. PubMed ID: 7068275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
    Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple electronic circuit for simulation of pharmacokinetic processes.
    Danek A; Poczatek J
    Arzneimittelforschung; 1976; 26(3):321-4. PubMed ID: 989320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug accumulation and dose finding (authors' transl)].
    Kurz H
    Arzneimittelforschung; 1977 Feb; 27(2A):250-3. PubMed ID: 577170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The repeated one-point method for predicting dose sizes with irregular dosing intervals.
    Thompson GA; Ritschel WA
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):337-43. PubMed ID: 3733283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining dosing intervals for luteinizing hormone releasing hormone agonists based on serum testosterone levels: a prospective study.
    Pathak AS; Pacificar JS; Shapiro CE; Williams SG
    J Urol; 2007 Jun; 177(6):2132-5; discussion 2135. PubMed ID: 17509298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the error of dose estimates and minimum and maximum acceptable concentrations from assays with nonlinear dose-response curves.
    Gottschalk PG; Dunn JR
    Comput Methods Programs Biomed; 2005 Dec; 80(3):204-15. PubMed ID: 16256244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
    Garrelts JC
    Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.